Douglas Boothe, president & chief executive officer of Akorn, said, “We are very pleased to announce Dandy as the newest member of the Akorn leadership team. Dandy’s deep expertise leading pharmaceutical organizations through challenging times will further strengthen Akorn. All quality functions will now be reporting to Dandy as part of our emphasis on accountability and cross-functional collaboration.”
03.22.19
Akorn, Inc. has announced that Dandy Dorado-Boladeres has been named as executive vice president of Global Quality, effective March 25, 2019.
Most recently, Mr. Dorado served as vice president of Quality Affairs at American Regent, where he served on the executive leadership team. Previously, he served as a senior vice president of Global Quality Services at Teva and vice president of International Quality Operations at Allergan/Actavis where he successfully led the integration of the Actavis Generics Quality Services unit with Teva.
Mr. Dorado brings decades of pharmaceutical industry experience and expertise with a focus on operational quality and technical services. Mr. Dorado will report directly to Douglas Boothe, Akorn’s president and chief executive officer, and play a critical role leading Akorn’s efforts to improve its operational efficiency and quality compliance.
Most recently, Mr. Dorado served as vice president of Quality Affairs at American Regent, where he served on the executive leadership team. Previously, he served as a senior vice president of Global Quality Services at Teva and vice president of International Quality Operations at Allergan/Actavis where he successfully led the integration of the Actavis Generics Quality Services unit with Teva.
